What's New

MDoutlook® Delivers Precision Intelligence

Post-ASH insight from MDoutlook available soon

Fresh on the heels of the conclusion of the 55th annual American Society for Hematology meeting (ASH), MDoutlook® has launched a series of its proprietary OncoPolls™. Developed to assess the immediate impact on disease management of new data presented at major meetings, this series focuses on multiple myeloma and chronic lymphocytic leukemia.

These OncoPolls are launched globally, reaching hematologic oncologists and other cancer treaters in more than 175 countries. Respondents include ASH participants and non-participants providing an opportunity to stratify the data based on how physicians have learned about the new clinical developments.

Pursuing our mission to advance cancer care and provide a collaboration platform between clinicians, ThoughtLeaders and life science companies, the results of these OncoPolls will be shared among our network of 75,000+ global cancer treaters (the largest of its kind in the world!) and our many industry contacts.

If you are interested in receiving a copy, discuss customized disease intelligence research or have any other question, please contact us by completing this short form or call us at 888.368.8566 / +1.404.496.4136.

Happy Holidays!
MDoutlook Team